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Heterogeneity in enterotoxigenic Escherichia coli and shigella 
infections in children under 5 years of age from 11 African 
countries: a subnational approach quantifying risk, 
mortality, morbidity, and stunting
Karoun H Bagamian, John D Anderson, Farzana Muhib, Oliver Cumming, Lindsey A Laytner, Thomas F Wierzba, Richard Rheingans
Summary
Background Diarrhoea, a global cause of child mortality and morbidity, is linked to adverse consequences including 
childhood stunting and death from other diseases. Few studies explore how diarrhoeal mortality varies subnationally, 
especially by cause, which is important for targeting investments. Even fewer examine indirect effects of diarrhoeal 
morbidity on child mortality. We estimated the subnational distribution of mortality, morbidity, and childhood 
stunting attributable to enterotoxigenic Escherichia coli (ETEC) and shigella infection in children younger than 5 years 
from 11 eastern and central African countries. These pathogens are leading causes of diarrhoea in young children and 
have been linked to increased childhood stunting.
Methods We combined proxy indicators of morbidity and mortality risk from the most recent Demographic and 
Health Surveys with published relative risks to estimate the potential distribution of diarrhoeal disease risk. 
To estimate subnational burden, we used country-specific or WHO region-specific morbidity and mortality estimates 
and distributed them subnationally by three indices that integrate relevant individual characteristics (ie, underweight, 
probability of receiving oral rehydration treatment of diarrhoea, and receiving vitamin A supplementation) and 
household characteristics (ie, type of drinking water and sanitation facilities).
Findings Characterising ETEC and shigella subnational estimates of indirect morbidity (infection-attributable 
stunting) and indirect mortality (stunting-related deaths from other infectious diseases) identified high-risk areas that 
could be missed by traditional metrics. Burundi and Democratic Republic of the Congo had the highest ETEC-
associated and shigella-associated mortality and stunting rates. Mozambique, Democratic Republic of the Congo, and 
Zimbabwe had the greatest subnational heterogeneity in most ETEC and shigella mortality measures. Inclusion of 
indirect ETEC and shigella mortality in burden estimates resulted in a 20–30% increase in total ETEC and shigella 
mortality rates in some subnational areas.
Interpretation Understanding the indirect mortality and morbidity of diarrhoeal pathogens on a subnational level will 
strengthen disease control strategies and could have important implications for the relative impact and cost-
effectiveness of new enteric vaccines. Because our methods rely on publicly available data, they could be employed for 
national planning.
Funding Bill & Melinda Gates Foundation.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Diarrhoea remains the second leading cause of global 
childhood mortality, despite recent estimates suggesting 
a 44% decline in global diarrhoea mortality from 
2000 to 2015.1 However, morbidity estimates show a 
modest decrease from 1·9 million to 1·7 million episodes 
for children younger than 5 years of age in the past 
20 years.2 The high incidence of diarrhoeal morbidity is 
concerning because studies have shown that repeated 
non-fatal diarrhoeal episodes might increase childhood 
stunting,3–5 which increases risk of mortality from other 
infectious diseases. Including these consequences in 
diarrhoeal mortality estimates provides a more complete 
picture of diarrhoea’s public health impact. Recent 
studies that included the impact of growth impairment 
in burden of diarrhoeal disease estimates in children 
have reported increases ranging from 24% to 153%.6–8
Diarrhoeal mortality and morbidity varies within and 
between countries.1,9 In many cases, this variation is 
caused by underlying patterns of poverty, insufficient 
access to essential services, and diverse living 
environments. Describing the heterogeneity in disease 
risk and burden has important implications for the 
effectiveness of disease interventions. Studies of 
infectious disease incidence have shown the importance 
of geographical differences in disease risk and burden 
when determining the impact and cost-effectiveness 
of intervention strategies.10,11 Although many studies 
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investigate the importance of heterogeneity in risk of 
malaria12 and measles,13 few studies explore subnational 
diarrhoeal heterogeneity.11 Unlike malaria, no agreed-
upon metric exists for diarrhoea to determine spatial 
heterogeneity. Heterogeneity in diarrhoeal risk and 
mortality burden can be further complicated by pathogen-
specific risks. When considering specific enteric 
pathogens or diarrhoeal mortality more broadly, very 
little information exists on differences within countries. 
Studies that evaluate diarrhoea within countries mostly 
focus on incidence or mortality patterns within one14 or 
a few countries9,15 and have not included indirect 
morbidity and mortality in their estimates.9,11
Recent multisite longitudinal studies in low-income 
countries have found that enterotoxigenic Escherichia coli 
(ETEC) and shigella are leading causes of moderate-to-
severe diarrhoea for children16,17 and diarrhoeal episodes 
attributed to these pathogens are associated with 
decreased linear growth in children younger than 
2 years.18 Recent estimates show that several countries in 
eastern and central Africa have high ETEC and shigella 
burden,17,19 with children younger than 5 years from this 
region having the highest ETEC mortality rates globally.19 
Therefore, we chose to explore the subnational patterns 
of ETEC and shigella morbidity and total mortality in this 
region. Here, we estimated the spatial distribution of 
diarrhoeal risk and ETEC and shigella direct morbidity 
and mortality, stunting cases attributable to ETEC and 
shigella, and deaths from other infectious diseases due 
to ETEC-attributable and shigella-attributable stunting 
in children across 11 countries in eastern and central 
sub-Saharan Africa.
Methods
Study overview and data sources
We developed disease burden models to estimate ETEC-
related and shigella-related mortality and morbidity for 
children younger than 5 years at the subnational level. We 
developed an index to score each child on the basis of 
specific weighted relative risks (RRs) of diarrhoeal 
mortality drawn from published literature (appendix 
pp 9–10). The risk index is composed of the RR related 
to the child’s exposure and susceptibility to diarrhoeal 
diseases (figure 1).20 We integrated recent methods for 
See Online for appendix
Research in context
Evidence before this study
Diarrhoea remains a leading cause of childhood mortality, 
but only recently have large-scale studies produced estimates 
of the aetiology of diarrhoeal disease in young children living in 
low-income and middle-income countries. Enterotoxigenic 
Escherichia coli (ETEC) and shigella are leading causes of 
diarrhoeal morbidity and mortality in children from 
low-income and middle-income countries and are linked to 
childhood stunting. The Global Burden of Diseases, Injuries, and 
Risk Factors Study has provided some cause-specific estimates 
of diarrhoeal burden, but these estimates are currently only 
available at national or global regional levels. Additionally, 
although a few studies have begun to include the indirect 
effects of diarrhoeal disease (eg, increased stunting leading to 
increased vulnerability to other infections and mortality from 
these infections) in their burden estimates, none of these 
studies include within-country estimates of ETEC and shigella 
burden. Another study has assessed overall diarrhoeal burden 
and severity at a subnational level across Africa, but these 
estimates were not cause specific. We searched the literature 
and found no studies that included mortality and morbidity 
burden estimates for ETEC and shigella at a subnational scale or 
that estimated ETEC and shigella burden including indirect 
mortality from ETEC-attributable and shigella-attributable 
stunting. We searched PubMed from inception to Feb 9, 2019, 
without language or location restrictions. We used two search 
strings: one for the diarrhoeal disease aetiology in children 
younger than 5 years and another on diarrhoea and stunting. 
For diarrhoeal aetiology in children younger than 5 years, we 
found 68 publications with the search string (“ETEC” OR 
“enterotoxigenic E coli” OR “enterotoxigenic” OR “shigella”) 
AND (“children under five” OR “children under 5” OR “children 
<5”) AND (“morbidity” OR “illness” OR “stunting” OR 
“episodes” OR “events” OR “cases”) AND (“cause” OR “etiology” 
OR “aetiology”). For diarrhoea and stunting, we found 
282 publications with the search string (“diarrhea” OR “diarrea” 
OR “diarrhoea”) AND (“stunting” OR “height for age” OR 
“height” OR “Z score”) AND (“child*” OR “children under five” 
OR “children under 5” OR “children <5”) AND (“outcomes” OR 
“changes”).
Added value of this study
We produced subnational estimates of ETEC and shigella 
morbidity, mortality, and stunting, as well as the indirect 
burden of deaths from other infectious diseases attributed to 
ETEC and shigella stunting, for children living in 11 eastern and 
central African countries. We integrated our previously 
published approach with methods for distributing burden 
estimates across subpopulations. Our study provides a more 
complete picture of diarrhoeal burden by including acute and 
potential outcomes of ETEC or shigella episodes at a finer 
spatial scale than previously published.
Implications of all the available evidence
Our analysis showed that within an area of the world with a 
high burden of diarrhoeal disease, there was considerable 
variation in ETEC and shigella burden. Subnational estimates 
revealed large variation in burden and identified susceptible 
populations of children with high disease burden, indicating the 
importance of within-country analysis. Assessing cause-specific 
estimates at the level at which policy makers can more 
effectively target interventions and investments is crucial to 
better reach the most vulnerable populations of children.
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estimating ETEC and shigella mortality, attributable 
stunting, and related mortality from other diseases8 and 
distributed our rate estimates subnationally using adjusted 
indices and rates.
To populate our models, we used child-level data 
from the 2011–17 Demographic and Health Survey 
(DHS)21 for 11 countries in eastern and central 
sub-Saharan Africa (appendix p 5). Countries in this 
analysis are contiguous and had recent DHS data 
available.21 All estimates derived from DHS data were 
calculated using appropriate survey weights. We used 
Malaria Atlas Project administrative unit level 1 child 
population estimates,22 aggregated into subnational 
units (referred to here as provinces), as appropriate per 
country (table 1).
Diarrhoeal mortality risk index
We calculated a diarrhoeal mortality risk index Ri for each 
child i (equation 1.1) that was the product of an exposure 
index Ei (equation 1.2) and a susceptibility index Si 
(equation 1.3). The exposure index is composed of the 
combined RR associated with m household-level expo-
sure factors and the susceptibility index is composed of 
the RRs of n child-level susceptibility factors (figure 1).
The three index scores were calculated for each child 
younger than 5 years using data from the DHS.21 We 
assumed that factors contributing to increased mortality 
burden were equivalent for ETEC and shigella because 
the necessary information to differentiate between the 
two is not available.
We used previously published RR estimates23 to assign 
a combined score Ei that assumed child exposure to 
diarrhoeal mortality risk was determined by two factors 
(thus, m = 2): the type of drinking water and the sanitation 
facilities used by their household (equation 1.2).20 The 
exposure score was the product of RRs associated with 
jth level of each exposure factor e, where each child could 
only be categorised into one level of each factor (appendix 
p 9). RR values were associated with three categories of 
drinking water sources (unimproved, off-plot improved, 
or on-plot improved) and with three categories of 
sanitation facilities (unimproved or no facility; improved 
and unshared sanitation on premises without a sewer 
connection; and improved and unshared sanitation on 
premises with a sewer connection) for a total of nine 
possible water and sanitation scenarios assigned to each 
individual child (appendix p 10).
We defined child susceptibility using three risk factors 
(thus, n=3) known to influence diarrhoeal mortality: 
child undernutrition defined by categories by weight for 
age, probability of receiving oral rehydration treatment of 
diarrhoea, and receiving vitamin A supplementation 
(equation 1.3; figure 1; appendix pp 2–3). The susceptibility 
score Si was the product of the RRs associated with the kth 
level of each susceptibility risk factor s for each child i, 
who could only be categorised into one level of each factor 
(equation 1.3; appendix p 9). Si was designed to be 
proportional to the excess risk associated with all three 
factors.
ETEC and shigella burden
We estimated national overall diarrhoeal mortality rates 
using the midpoint of 2016 WHO Maternal Child 
Epidemiology Estimation24 and Global Burden of Diseases, 
Injuries, and Risk Factors Study (GBD)25 diarrhoeal 
mortality estimates, adjusted for countries that introduced 
the rotavirus vaccine.8 We calculated the national ETEC 
and shigella mortality rates for each country c by 
multiplying national diarrhoeal mortality rates Dc with 
culture-based aetiological fractions26 adjusted with 
Figure 1: Conceptual framework of the diarrhoeal mortality risk model
Underweight Vitamin
A
Geography
Water
Poverty
Sanitation
Oral
rehydration
therapy
Exposure factors
Susceptibility factors
Diarrhoea
Stunting
Mortality
Health outcomes
Survey 
year
DHS 
phase
Subnational unit of measure
Burundi 2016–17 DHS-VII Administrative unit 1 (18 provinces)
Democratic 
Republic of 
the Congo
2013–14 DHS-VI Administrative unit 1 (by 11 regions based on former provinces and 
includes one city, Kinshasa)
Ethiopia 2016 DHS-VII Administrative unit 1 (by nine regional states and two chartered cities)
Kenya 2014 DHS-VII Administrative unit 1 (by eight regions based on former provinces)
Malawi 2015–16 DHS-VII Administrative unit 1 (by three regions)
Mozambique 2011 DHS-VI Administrative unit 1 (by ten provinces and one chartered city)
Rwanda 2014–15 DHS-VII DHS-determined five regional groupings of administrative 1 areas
Tanzania 2015–16 DHS-VII DHS-determined eight regional groupings of administrative 1 areas
Uganda 2016 DHS-VII 15 subregional groupings of districts
Zambia 2013–14 DHS-VI Administrative unit 1 (by ten provinces)
Zimbabwe 2015 DHS-VII Administrative unit 1 (by ten provinces)
DHS=Demographic and Health Survey.
Table 1: List of countries from east and central Africa included in the analysis
Ri = Ei ⋅ Si 
Ei = ∏
m
e = 1
(RRe,j ⋅ ej)i
Si = ∏
n
s = 1
(RRs,k ⋅ sk)i
(1.1)
(1.2)
(1.3)
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molecular estimates xp for each pathogen p 
(appendix pp 7, 11).16 We generated provincial ETEC and 
shigella mortality rates ds,p by multiplying national mortality 
rates by the quotient from dividing the mean diarrhoeal 
mortality risk index score Rs for each province s by the 
national mean risk score Rc for the corresponding country:
This ensured that the average of provincial mortality rates 
ds remained equal to the national mortality estimates.
We estimated the number of national ETEC and shigella 
moderate-to-severe diarrhoeal episodes by multiplying the 
WHO regional diarrhoeal incidence, Mc (currently 
3·3 episodes per child per year),27 by aetiological fractions 
x for each pathogen p. On the basis of prior assumptions 
on health-care use28 and estimates from the Global Enteric 
Multicenter study,17 we assumed that 10% of diarrhoeal 
episodes were considered moderate to severe.8 We 
distributed ETEC or shigella episodes across provinces by 
multiplying national rates of moderate-to-severe 
diarrhoeal episodes by the quotient from dividing the 
mean provincial exposure score Es by the mean exposure 
score Ec for the corresponding country:
Using previous methodology8 and population shifts 
in height-for-age Z scores due to ETEC and shigella 
moderate-to-severe diarrhoeal episodes reported by the 
Global Enteric Multicenter study,17 we modelled the 
portion of childhood stunting attributed to ETEC and 
shigella infections. We then estimated the expected 
mortality from other infectious diseases as a result 
of ETEC-attributable or shigella-attributable stunting, 
hereafter referred to as indirect mortality. First, we 
used province-level data from the DHS28 to estimate the 
proportions of children with height-for-age Z scores less 
than 2 SDs (moderately stunted) or 3 SDs (severely 
stunted) below the mean height-for-age Z score. We 
constructed height-for-age Z score distributions Xs for 
each province using estimates of moderately and severely 
stunted children, then simulated a hypothetical height-
for-age Z score distribution, Xsʹ, excluding the shift (∆) 
attributed to ETEC and shigella moderate-to-severe 
diarrhoeal episodes (equations 2.1 and 2.2).17 
We used the differences in probabilities of moderate 
stunting (Ya) and severe stunting (Yb) from the estimated 
and hypothetical distributions to calculate the increased 
fraction of moderately and severely stunted children in 
each province (equations 2.3 and 2.4).
We included country-specific child mortality rate 
estimates from 2016 WHO Maternal Child Epidemiology 
Estimation24 and GBD25 for diarrhoea, malaria, pneu-
monia, and measles—diseases for which childhood 
moderate and severe stunting is a known risk factor.29,30 
We used the population attributable risk (PAR) approach:
with fractions of ETEC-induced or shigella-induced 
moderate and severe stunting as the risk factor proportion 
Pe and the relative mortality risk RRe associated with 
different moderate and severe stunting levels from 
Black et al.30
We estimated province-level mortality rates dID,s for each 
infectious disease, ID, and each province, s, as the product 
of national child mortality rates DID,c and the quotient from 
dividing DHS28 all-cause provincial mortality rates for 
children younger than 5 years, Us, by the mean national 
all-cause subnational mortality rate, Uc, from the DHS:
This ensured that the average of provincial infectious 
disease mortality rates within each country remained 
equal to national infectious disease mortality estimates. 
We report total mortality as the sum of direct mortality 
(from acute ETEC or shigella infection) and indirect 
mortality (other infectious disease deaths from ETEC-
attributable or shigella-attributable stunting).
Data and spatial analyses
We used complex survey design in Stata 14.2 for 
all statistical estimates, risk model imputations, and 
reported results, and report 95% CIs for our weighted 
means, calculated in Stata. We used ArcGIS version 10.6 
(ESRI, Redlands, CA, USA) for all spatial analyses. We 
constructed the diarrhoeal mortality risk heat map by 
interpolating cluster-level weighted risk averages 
across 11 countries’ surfaces using the empirical 
Bayesian kriging tool in the ArcGIS Spatial Analyst 
extension.31 We calculated the root squared mean error 
(RMSE) of several iterations of the empirical Bayesian 
kriging interpolation varying the input parameters, 
and included the one with the lowest RMSE here 
(appendix pp 2–4).32 The RMSE is the square root of the 
average difference between measured and predicted 
values and indicates how well predicted values 
correspond to measured values; ideally, the further 
ds,p = (Dc ⋅ xp) ⋅ 
Rs
Rc
ms,p = (Mc ⋅ xp) ⋅ 
Es
Ec
Xs ~ N(μ, σ2)
X's ~ N(μ', σ2) where μ' = μ + ∆
Ya = [(μ − 2σ) − (μ − 3σ)] − [(μ' − 2σ) − (μ' − 3σ)]
Yb = (μ − 3σ) − (μ' − 3σ)
(2.1)
(2.2)
(2.3)
(2.4)
PAR =
Pe(RRe – 1)
1 + Pe(RRe – 1)
dID,s = DID,c ⋅  
Us
Uc
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away from 1 the RMSE, the better the model. The heat 
map is intended as a visualisation of risk over the study 
site.
Sensitivity analysis
We did one-way sensitivity analyses in Sensit version 1.53 
(TreePlan Software, San Francisco, CA, USA) to assess the 
impact of individually varying model inputs on our ETEC 
and shigella total mortality estimates (appendix p 7). 
Using SimVoi version 3.07 (TreePlan Software), we 
assessed the effect of simultaneous changes in multiple 
input variables through uncertainty analysis using Monte 
Carlo simulations. We ran our model for 10 000 iterations 
and estimated the upper (97·5%) and lower (2·5%) 
95% uncertainty interveals (UIs) for key outputs (appendix 
p 11), which are reported along with our point estimates.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all of the data, and the final responsibility to submit for 
publication.
Results
The percentage of moderate-to-severely underweight 
children younger than 5 years ranged from 11·2% to 
35·7% by country (table 2); the Democratic Republic of 
the Congo (DRC), Ethiopia, and Burundi had the highest 
percentage. The percentage of children receiving 
preventive vitamin A was slightly higher (37·7–79·8%) 
than children receiving oral rehydration treatment 
(32·2–71·4%), although this pattern varied per country 
(table 2).
In all countries, low percentages of children lived in 
households with improved water and sanitation access, 
ranging from 0·0% (Mozambique) to 9·7% (Zimbabwe) 
for piped sanitation and from 5·5% (Rwanda) to 30·9% 
(Zimbabwe) for on-plot improved water (table 2). Less 
than 50% of children had access to improved, unshared 
sanitation in most countries, except for Rwanda and 
Malawi (table 2). Higher percentages of surveyed children 
Burundi DRC Ethiopia Kenya Malawi Mozambique Rwanda Tanzania Uganda Zambia Zimbabwe
Underweight
Number assessed 6063 8388 8975 18 909 5232 9830 3533 9052 4444 11 799 5012
Moderate to severe 35·7% 
(34·2–37·2)
26·3% 
(24·5–28·0)
28·4% 
(26·7–30·1)
14·8% 
(13·9–15·7)
15·1% 
(13·9–16·3)
18·4% 
(17·4–19·5)
12·0% 
(10·8–13·3)
18·0% 
(16·8–19·2)
12·8% 
(11·6–14·0)
19·1% 
(18·2–20·0)
11·2% 
(10·2–12·3)
Severe 8·1% 
(7·3–8·9)
6·3% 
(5·6–7·1)
6·1% 
(5·4–6·9)
2·3% 
(2·0–2·5)
1·7% 
(1·3–2·2)
3·6% 
(3·1–4·1)
2·0% 
(1·6–2·5)
2·4% 
(1·9–2·8)
2·0% 
(1·5–2·5)
3·0% 
(2·6–3·4)
1·4% 
(1·0–1·8)
Access to care
Oral rehydration therapy
Number assessed 12 472 17 082 10 006 19 798 16 462 10 291 7364 9707 14 710 11 799 5807
Received treatment 37·2% 
(36·8–37·5)
41·3% 
(40·6–42·0)
38·0% 
(37·3–38·6)
63·7% 
(63·5–63·9)
71·4% 
(71·3–71·6)
60·5% 
(59·7–61·3)
32·2% 
(32·0–32·4)
45·2% 
(44·6–45·8)
48·9% 
(48·5–49·3)
69·5% 
(69·3–69·8)
70·4% 
(69·9–70·9)
Vitamin A
Number assessed 12 439 16 947 9805 19 850 16 304 10 208 7352 9506 14 471 12 380 5731
Received treatment 64·9% 
(63·2–66·5)
65·7% 
(63·6–67·9)
41·4% 
(39·0–43·8)
68·0% 
(66·8–69·2)
61·3% 
(60·0–62·6)
66·8% 
(65·0–68·6)
79·8% 
(78·7–80·9)
37·7% 
(35·9–39·6)
57·2% 
(55·7–58·7)
69·1% 
(67·7–70·5)
61·8% 
(59·3–64·2)
Sanitation
Number assessed 13 192 18 715 10 641 20 958 17 286 11 102 7698 10 233 15 522 13 437 6132
Unimproved or no facility 58·8% 
(57·0–60·6)
82·5% 
(79·9–85·2)
90·0% 
(88·8–91·3)
78·8% 
(77·1–80·5)
49·4% 
(47·8–51·1)
80·5% 
(78·9–82·1)
42·1% 
(40·3–43·9)
85·1% 
(83·4–86·7)
95·6% 
(94·9–96·3)
77·2% 
(75·3–79·1)
68·2% 
(65·4–70·9)
Improved and unshared 
without a sewer connection
41·1% 
(39·3–42·9)
17·4% 
(14·7–20·0)
9·7% 
(8·4–10·9)
18·3% 
(16·8–19·8)
50·2% 
(48·6–51·8)
19·5% 
(17·9–21·1)
57·4% 
(55·6–59·2)
14·8% 
(13·2–16·4)
4·1% 
(3·4–4·7)
17·8% 
(16·2–19·4)
22·1% 
(19·6–24·6)
Improved and unshared with a 
sewer connection*
0·0% 
(0·0–0·1)
0·1% 
(0·0–0·3)
0·3% 
(0·1–0·4)
2·9% 
(2·0–3·7)
0·4% 
(0·0–0·8)
·· 0·5% 
(0·3–0·7)
0·1% 
(0·0–0·2)
0·4% 
(0·2–0·5)
4·9% 
(3·8–6·1)
9·7% 
(8·0–11·5)
Water source
Number assessed 13 192 18 709 10 641 20 964 17 286 11 102 7698 10 233 15 522 13 457 6132
Surface or unimproved 18·0% 
(15·9–20·2)
53·5% 
(49·0–58·1)
43·7% 
(38·8–48·5)
35·7% 
(33·6–37·7)
13·5% 
(11·8–15·3)
50·5% 
(47·1–53·9)
27·5% 
(24·7–30·2)
48·6% 
(45·3–52·0)
23·1% 
(20·7–25·5)
40·1% 
(37·7–42·6)
25·4% 
(22·0–28·8)
Off-plot improved 73·9% 
(71·5–76·2)
40·6% 
(36·3–45·0)
45·8% 
(41·2–50·3)
35·8% 
(33·7–38·0)
74·2% 
(72·1–76·2)
38·9% 
(35·5–42·3)
67·0% 
(64·2–69·8)
31·0% 
(28·1–33·9)
62·5% 
(60·0–65·1)
43·6% 
(40·7–46·4)
43·7% 
(40·3–47·0)
On-plot improved 8·1% 
(6·8–9·5)
5·8% 
(4·6–7·0)
10·6% 
(8·7–12·5)
28·5% 
(26·6–30·4)
12·3% 
(11·0–13·6)
10·6% 
(9·4–11·9)
5·5% 
(4·4–6·7)
20·4% 
(18·1–22·7)
14·3% 
(12·4–16·2)
16·3% 
(14·4–18·2)
30·9% 
(28·0–33·9)
Data are number of children assessed or weighted mean (95% CI) for each category. Weighted means and 95% CIs were calculated while accounting for survey design. DRC=Democratic Republic of the Congo. 
*The Demographic and Health Survey for Mozambique did not include sewer connections when categorising sanitation facilities.
Table 2: Distribution of underlying diarrhoeal risk factors for children younger than 5 years across eastern and central African countries
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had access to on-plot or off-plot improved water 
(46·4–86·5%) than improved sanitation (table 2).
Overall diarrhoeal mortality risk was heterogeneous, 
with areas of higher and lower risk within each country 
(figure 2). Some countries had areas of marked 
concentrated risk (eg, Mozambique and Zimbabwe), 
whereas others had more diffuse patterns of risk over a 
large area (eg, Kenya and southern Ethiopia). The RMSE 
of this visualisation was 0·39.
Children with the highest annual inci dence of ETEC 
moderate-to-severe diarrhoeal episodes were from four 
Zimbabwean provinces—Mashonaland Central and West, 
Matabeleland North, and Masvingo, ranging from 
2804 episodes (95% UI 923–4321) to 2879 episodes 
(947–4436) per 100 000 children—and from the Northern 
province in Zambia, with 2803 epi sodes (923–4320) per 
100 000 children (figure 3; appendix pp 12–20). Children 
with the highest annual incidence of shigella moderate-
to-severe diarrhoeal episodes were found in the provinces 
mentioned above, as well as Mashonaland East in 
Zimbabwe (3008 episodes [1012–4535]); Muchinga, 
North Western, and Western provinces in Zambia 
(ranging from 3015 episodes [1014–4544] to 3065 episodes 
[1031–4619]); Western province in Tanzania (3023 epi -
sodes [1017–4556]); Zambezia province in Mozambique 
(3010 episodes [1013–4538]); and North Eastern (3040 epi -
sodes [1023–4583]) and Western (3005 episodes [1011–4530]) 
provinces in Kenya (figure 4; appendix pp 21–28).
Although there was some subnational heterogeneity in 
moderate-to-severe diarrhoeal episodes for either disease 
within most countries (figures 3, 4), it was small. For 
countries other than Zimbabwe, the provinces with the 
highest episode incidences were usually less than 
1·5 times the incidence of the province with the lowest 
incidence (appendix pp 12–28). In Zimbabwe, the episode 
incidence was almost 1·8 times greater in Mashonaland 
Central compared with Bulawayo (appendix pp 12–28).
Children with the highest annual incidence of ETEC-
attributable stunting cases were from half of Burundi’s 
provinces distributed throughout the north (ranging from 
403 cases [95% UI 131–631] to 460 [150–721] cases per 
100 000 children), four of DRC’s provinces (Bas Congo, 
Kasai Occidental, Nord Kivu, and Sud Kivu, ranging 
from 415 cases [136–650] to 456 cases [149–715] per 
100 000 children), and two northeastern provinces from 
Mozambique (421 cases [138–660] per 100 000 children in 
Cabo Delago and 420 [137–658] in Nampula; figure 3; 
appendix pp 12–20). For shigella, children with highest 
stunting incidence rates were from the same provinces as 
those with the highest ETEC stunting rates, followed 
closely by Afar and Benishangul-Gumuz (507 cases 
[167–775] per 100 000 children for both) in Ethiopia, Niassa 
(524 cases [172–800]), and Zambezia (517 cases [170–790]) 
in Mozambique, and Luapula (507 cases [167–775]) and 
Northern province (526 cases [173–803]) in Zambia 
(figure 4; appendix pp 21–28).
Most study countries showed subnational variation in 
ETEC-attributable and shigella-attributable stunting 
incidence, with Mozambique, DRC, and Uganda having 
the greatest variation (figures 3, 4). In Mozambique, 
children in the northwestern two provinces had the 
highest stunting incidence rates for either disease, 
and this decreased going southwest, with the southern-
most province having the lowest stunting incidence 
(figures 3, 4). Within DRC, most subnational areas had 
rates equivalent to the national estimates, except for 
Kinshasa’s stunting incidence being less than half of the 
national stunting incidence. Within Uganda, provinces 
on the eastern and western borders had higher rates 
than the central provinces (figures 3, 4).
The highest annual direct ETEC mortality rates for 
children were in 16 of 18 Burundi provinces (ranging 
from 15·2 deaths [10·4–20·7] to 23·9 deaths [16·4–32·6] 
per 100 000 children); followed by five provinces in north 
to central DRC (15·5 deaths [10·6–21·1] to 16·9 deaths 
[11·6– 23·0]); a central province (Midlands) in Zimbabwe 
Figure 2: Heat map of relative diarrhoeal risk for children younger than 5 years across 11 eastern and central 
African countries
Displayed surfaces are of spatial interpolations (predictions) estimated from cluster-level average diarrhoeal risk 
calculations using data from national Demographic and Health Surveys. Higher numbers indicate higher risk.
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(18·6 deaths [12·7–25·3]); and the northeastern prov-
ince of Cabo Delgado in Mozambique (15·8 deaths 
[10·9–21·6]; figure 3; appendix pp 12–20). Children in 
these provinces also had high direct shigella mortality, 
along with children from two additional provinces in 
central and south DRC and two additional central 
provinces in Zimbabwe (≥15 deaths per 100 000 children; 
figure 4; appendix pp 21–28). Overall, direct mortality 
ranged from 1·5 (UI 1·0–2·0) to 23·9 (16·4–32·6) deaths 
per 100 000 children for ETEC and 1·6 (1·2–2·1) to 
26·2 (19·0–34·4) deaths per 100 000 children for shigella.
The provinces with the highest annual indirect 
child mortality rates were Kirundo (ETEC: 6·2 deaths 
[UI 2·0–9·6] and shigella: 8·1 deaths [2·7– 12·3] per 
Figure 3: Maps of subnational estimates of ETEC burden, mortality, diarrhoeal episode incidence, and stunting incidence in children younger than 5 years across 11 eastern and central African 
countries
Mortality and incidence are given per 100 000 children younger than 5 years per year. Total mortality burden is the sum of direct and indirect mortality rates, where indirect mortality is deaths from 
other infectious diseases from ETEC-attributable stunting. ETEC=enterotoxigenic Escherichia coli.
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100 000 children) in Burundi; and Sud Kivu (ETEC: 
6·0 deaths [2·0– 9·3] and shigella: 7·9 deaths [2·6– 11·9]) 
and Kasai Occidental (ETEC: 5·8 deaths [1·9– 8·9] and 
shigella: 7·5 deaths [2·5–11·4]) in DRC. These were 
followed closely by several other provinces in Burundi 
and DRC (figures 3, 4; appendix pp 12–28).
On average across the 110 provinces, indirect mortality 
accounted for 15·7% (ETEC) and 18·2% (shigella) of the 
total burden. For many provinces in Burundi, DRC, 
Ethiopia, and Mozambique, indirect mortality accounted 
for a quarter to a third of the total mortality (appendix 
pp 12–28).
Figure 4: Maps of subnational estimates of shigella burden, mortality, diarrhoeal episode incidence, and stunting incidence in children younger than 5 years across 11 eastern and central 
African countries
Mortality and incidence are given per 100 000 children younger than 5 years per year. Total mortality burden is the sum of direct and indirect mortality rates, where indirect mortality is deaths from 
other infectious diseases from shigella-attributable stunting. Shigella estimates had a higher range of values than ETEC estimates because of its higher aetiological fraction and Z score shift. 
ETEC=enterotoxigenic Escherichia coli.
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ETEC and shigella total mortality annual rates were 
highest for children in Burundi (>20 deaths per 
100 000 children in 14 provinces for ETEC and 
16 provinces for shigella; figures 3, 4). For ETEC total 
mortality, other provinces with high annual mortality 
rates for children were almost half of the 11 provinces in 
DRC, Cabo Delgado in Mozambique, and Midlands in 
Zimbabwe (figure 3; appendix pp 12–20). These areas 
also had high shigella total mortality rates for children, 
with the addition of two provinces in DRC (figure 4; 
appendix pp 21–28).
Mozambique, DRC, and Zimbabwe displayed high 
subnational variation in most ETEC and shigella mor-
tality measures, while Kenya, Tanzania, Ethiopia, and 
Uganda had no to little variation in mortality measures 
(figures 3, 4). Mozambique had the highest heterogeneity 
in ETEC and shigella direct mortality rates, with the 
central estimates of three provinces (Cabo Delgado, Tete, 
and Zambezia) having rates at least 1·5 times the national 
rate estimates. Cabo Delgado, the province with the 
highest rates in Mozambique, had a central rate estimate 
almost five times higher than its neighbouring province 
with the lowest rate estimate, Niassa (appendix pp 12–28). 
Mozambique also had the highest heterogeneity in 
indirect death rate estimates. Children in Cabo Delgado 
and Zambezia provinces had central indirect death rate 
estimates 1·6–1·8 higher than national rates and 4–5 times 
higher, respectively, than Maputo, the province with the 
lowest central rate estimate (appendix pp 12–28). Within 
DRC, variation existed in direct ETEC and shigella 
mortality rates, displaying a similar pattern to the stunting 
pattern described above (figures 3, 4). However, children 
in DRC from Sud Kivu and Kasai Occidental had central 
indirect mortality rate estimates from disease-attributable 
stunting 1·5 times the national rate estimate (appendix 
pp 12–28). In Zimbabwe, there was hetero geneity in direct 
ETEC and shigella mortality rates but not in indirect 
mortality rates. Children from Midlands had a central 
ETEC mortality rate estimate 1·5 times higher than the 
national rate estimate, and more than five times higher 
than the province with the lowest central rate estimate in 
Zimbabwe, Bulawayo (appendix pp 12–28).
For most countries, children in the two lowest wealth 
quintiles were more likely to have higher risk index values 
than children from the highest wealth quintile, both in 
rural and urban settings (appendix p 29). Rural households 
had higher risk indices than the urban households for 
their corresponding wealth quintile in all countries 
(appendix p 29). There was a larger disparity in risk 
between children from the highest and lowest wealth 
quintiles in urban areas compared with their counterparts 
in rural areas. On average, children from urban 
households in the lowest quintile had three times the risk 
of children in the highest quintile, with some countries 
having a notably higher disparity (eg, Burundi and 
Ethiopia). On average, the children from rural households 
in the lowest quintile had twice the risk as compared with 
those in rural households in the highest quintile, and one 
country (Mozambique) had a higher disparity (appendix 
p 29). 
The variables with the greatest effect on the total ETEC 
and shigella mortality burden across the 110 provinces in 
this study were the molecular adjustments (swing of 
56·2% [ETEC] and 41·2% [shigella] from base case 
estimates); the aetiological fractions attributed to each 
pathogen (32·3% [ETEC] and 41·2% [shigella] from base 
case estimates); and the fraction of moderate-to-severe 
diarrhoeal episodes that cause a height-for-age Z score 
shift (6·1% [ETEC] and 10·5% [shigella] from base case 
estimates; appendix p 8). The variables with the greatest 
effect on cases of moderate and severe stunting were the 
fraction of moderate-to-severe diarrhoeal episodes that 
cause a height-for-age Z score shift (61·0% [ETEC] and 
65·9% [shigella] from base case estimates); molecular 
adjustments (17·0% [ETEC] and 10·5% [shigella] from 
base case estimates); and the aetiological fractions 
attributed to each pathogen (9·8% [ETEC] and 10·5% 
[shigella] from base case estimates).
Discussion
To the best of our knowledge, this is the first study to 
quantify ETEC and shigella morbidity and total mortality, 
both from infection and from the consequences of 
diarrhoea-associated stunting, at the subnational level for 
several sub-Saharan African countries. This is a scale of 
analysis little explored by current diarrhoeal research but 
crucial to improving intervention strategies. Quantifying 
heterogeneity identified high-burden provinces with 
relatively low ETEC and shigella mortality from acute 
infection, but with total ETEC and shigella mortality 
estimates a quarter to a third higher once infectious 
disease deaths from ETEC-attributable and shigella-
attributable stunting were included.
Our metrics identified that the highest total mortality 
rates for ETEC and shigella were in Burundi; most 
provinces of Burundi had the highest incidences of 
stunting across our study countries. Many DRC 
provinces also had high total ETEC and shigella mortality 
rates and high incidences of stunting. High morbidity 
and mortality rates from ETEC and shigella infections 
in these countries were probably driven by the 
high percentage of moderately-to-severely underweight 
children (eg, 35·7% of children younger than 5 years in 
Burundi and 26·3% in DRC).
Our subnational analysis, which included indirect 
burden measures, identified geographical areas with high 
mortality from ETEC-attributable and shigella-attributable 
stunting that would have been less apparent if our models 
had only included direct diarrhoeal mortality. We also 
identified areas of high direct mortality burden within 
Zimbabwe and other countries that would have been 
undetected at a national scale. For example, when 
assessed at a national level, children from Zimbabwe had 
lower risk compared with children from the other study 
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countries. However, our analysis identified Midlands as 
having higher direct burden than almost all the other 
provinces. A recent study using a high-resolution 
Bayesian geo statistical model found this area in 
Zimbabwe to be one of only five subnational areas within 
Africa with an increase in diarrhoeal mortality from 
2000 to 2015.11 These obser vations taken together confirm 
the importance of assessing the total mortality envelope 
at different spatial scales. Understanding within-country 
heterogeneity can help to distinguish subpopulations that 
will benefit most from water, sanitation, and hygiene 
(WASH) interventions and deployment of enteric 
vaccines, while also identifying communities to study 
further on cause-specific risk and burden. Our findings 
corroborate others11 that even within high-risk and high-
burden countries of the world, certain subpopulations 
bear a disproportionate amount of burden.
By including indirect burden, our total ETEC and 
shigella mortality estimates increased by an average of 
15·7% and 18·0%, respectively—a conservative increase 
compared with other global studies6,7 that included 
indirect burden associated with other diarrhoeal causes 
in their estimates at broader spatial scales. For the 
provinces in our study, Reiner and colleagues11 reported 
overall direct diarrhoeal mortality rates that ranged from 
100 to 150 deaths per 100 000 children. Our estimates 
(after applying our assumed aetiological fractions) fit 
within the range of these model outputs with direct rates 
of 1·5 (UI 1·0–2·0) to 23·9 (16·4–32·6) deaths per 
100 000 children for ETEC and 1·6 (1·2–2·1) to 26·2 
(19·0–34·4) deaths per 100 000 children for shigella.
The overall pattern of subnational heterogeneity in 
mortality rates in our study and Reiner and colleagues11 
was similar for all study countries, except for 
Mozambique. Although we used the same DHS as our 
basis of analysis, the main reason for this discrepancy is 
probably because of the methods employed: we used 
child-oriented and exposure-related variables to distribute 
our estimates, and these regions of Mozambique have 
high exposure risk and high under-5 mortality. We offer 
our estimates as a different way of viewing diarrhoeal 
burden. Future subnational studies should explore 
diarrhoeal mortality and morbidity burden by cause 
across larger high-risk regions to capture local variation 
in aetiological-specific burden, as pathogens with dif-
ferent ecologies could thrive in different environmental 
conditions. Additionally, future assessment of sub-
national total burden related to ETEC and shigella 
infection should incorporate other ecological and 
environmental covariates to produce a more accurate 
high-resolution spatial projection.
Osgood-Zimmerman and colleagues33 assessed spatio-
temporal trends in child growth failure at high spatial 
resolution across sub-Saharan Africa using prevalence 
data from the DHS and other sources. Although many 
of our provinces with high rates of ETEC and shigella 
stunting had a high prevalence of moderate and severe 
stunting in their study (eg, Nord Kivu, Sud Kivu, and 
Maniema in DRC and many provinces in Burundi), 
observed differences between our results and theirs in 
Ethiopia, Zambia, and Kenya can potentially be 
attributed to the dates of the surveys used (2010 Ethiopia 
survey vs 2016 in our study) and different organisation 
of subnational demarcations (Zambia and Kenya). 
Indeed, as Osgood-Zimmerman and colleagues 
discussed,33 Ethiopia showed substantial decreases in 
child undernutrition from 2005 to 2015.15 The largest 
dissimilarity in our results are for certain regions in 
Mozambique (eg, Cabo Delgado and Nampula for ETEC 
and all four northeastern Mozambique provinces for 
shigella). Our results show high prevalence of ETEC 
and shigella stunting, which Osgood-Zimmerman and 
colleagues33 have shown to be in the mid-range of 
stunting for these regions. This difference is due to our 
use of child exposure risk as explained above, which 
results in a higher likelihood of experiencing diarrhoea 
and its downstream effects according to our model.
All our shigella burden estimates were higher than our 
ETEC estimates because of its higher aetiological fraction 
than ETEC; this difference was even more pronounced in 
our stunting and indirect mortality estimates because, in 
addition to the higher aetiological fraction, there also is a 
higher Z score shift associated with shigella episodes. In 
Khalil and colleagues,19 they observed a similar pattern, 
where their shigella national mortality estimates were 
higher than their ETEC national mortality estimates for 
the same reason.
While there was substantial variation in risk, our sup-
plemental analysis of risk index by economic status and 
household setting (appendix p 29) indicated that these are 
additional influential factors that should be considered 
when assessing risk and burden heterogeneity. Most 
notably, household economic status is a clear indirect factor 
in determining risk. Its effects are the results of combined 
inequality in underlying under nutrition, health-care access, 
and ecological exposure variables. Future investigators 
should also evaluate the impact and cost-effectiveness of 
ETEC and shigella vaccination inter ventions subnationally. 
These differences are important to consider when planning 
effective interventions and are likely to affect the impact 
and cost-effectiveness of vaccination.
Although our model relies on well characterised and 
established factors related to susceptibility and 
exposure, we used proxy measures for risk and do not 
have aetiological confirmation of diarrhoeal episodes 
for DHS-surveyed children. Additionally, we used data 
on oral rehydration treatment use (oral rehydration 
solution and recommended home solution) in assessing 
differences across subpopulations, yet we relied on oral 
rehydration solution effectiveness for determining the 
relative effect of those differences in behaviours. This is 
because, to our knowledge, there is no robust estimate 
of the effectiveness of recommended home solution 
compared with oral rehydration solution. Because 
Articles
www.thelancet.com/lancetgh   Published online November 13, 2019   https://doi.org/10.1016/S2214-109X(19)30456-5 11
recommended home solution is more common in more 
marginalised subpopu lations, leaving it out of the 
analysis would overstate the disparity between 
marginalised and more privileged subpopulations. 
In addition, there are other differences in treatment 
(eg, antibiotic availability, treatment timing, zinc 
supplementation) that we did not account for in our 
model, because full data are not available on the use and 
effects of these risk factors. Current methods of 
attributing aetiological causes of diarrhoea are not 
perfect; while traditional culture-based methods under-
estimate the presence of pathogens, molecular methods 
might over estimate them. As we used molecularly 
adjusted aetiological fractions in our study, we might be 
over estimating their presence. Although there is 
growing availability of country-level modelled estimates 
of diarrhoeal episode incidence, we relied on WHO 
regional-level estimates for this analysis. We did so to 
increase transparency and avoid adding additional 
model uncertainty to our estimates, but this probably 
understates episode heterogeneity across countries. 
Also, the similarities between the distribution of 
ETEC and shigella burden are a result of our assumption 
that factors contributing to increased mortality were 
equivalent for ETEC and shigella, in light of the lack of 
data to differentiate between the mortality risk attributed 
to infection by these pathogens. Improved estimates of 
the differential burden including case fatality rates of 
the two pathogens could greatly improve public health 
decision making about vaccines or WASH in these 
high-risk and resource-constrained settings. Our 
subnational estimates would be improved by 
longitudinal studies of community-level infection 
patterns of ETEC and shigella, which could help to 
validate our model’s assumptions and refine burden 
estimates. While the DHS’s cluster-based sampling 
survey design provides an unevenly distributed dataset 
not ideal for basic spatial interpolations, we 
implemented a previously used32 interpolation approach 
that can be used to effectively project DHS data. Our 
heat map of risk is a visualisation tool, and its RMSE is 
higher than other diarrhoeal maps.11 In future studies, 
inclusion of spatial covariates in our interpolation 
models might improve their fit. Anderson and 
colleagues8 provided specific caveats for our methods of 
burden estimation.
We showed that assessing diarrhoeal disease risk and 
ETEC and shigella infection-associated morbidity and 
total mortality at a subnational level can identify 
previously undetected high-burden areas. Our emphasis 
on provincial differences identified potentially 
susceptible populations that would benefit most from 
interventions and that would not have been identified 
through traditional measures, providing country-level 
decision makers with valuable information to help to 
prioritise the implementation of interventions in 
resource-constrained settings.
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